Pharmacoeconomic evaluation of Simulect prophylaxis in renal transplant recipients

被引：8

作者：

Walters, SJ ^{[1
]}

Whitfield, M ^{[1
]}

Akehurst, RL ^{[1
]}

Chilcott, JB ^{[1
]}

机构：

[1] Univ Sheffield, ScHARR, Sheffield Hlth Econ Grp, Sheffield S1 4DA, S Yorkshire, England

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02356-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：3187 / 3191

页数：5

共 17 条

[1] PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL-ANTIBODY USED IN CADAVERIC RENAL-TRANSPLANTATION [J].

AMLOT, PL ;

RAWLINGS, E ;

FERNANDO, ON ;

GRIFFIN, PJ ;

HEINRICH, G ;

SCHREIER, MH ;

CASTAIGNE, JP ;

MOORE, R ;

SWENY, P .

TRANSPLANTATION, 1995, 60 (07) :748-756

[2]

Armitage P., 2001, STAT METHODS MED RES, V4th

[3]

ARNLOT PL, 1995, MONOCLONAL ANTIBODIE, P53

[4] Improved graft survival after renal transplantation in the United States, 1988 to 1996. [J].

Hariharan, S ;

Johnson, CP ;

Bresnahan, BA ;

Taranto, SE ;

McIntosh, MJ ;

Stablein, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :605-612

[5] CAUSES OF LATE RENAL-ALLOGRAFT FAILURE IN THE CYCLOSPORINE ERA [J].

HONG, JH ;

SUMRANI, N ;

DELANEY, V ;

DAVIS, R ;

DIBENEDETTO, A ;

BUTT, KMH .

NEPHRON, 1992, 62 (03) :272-279

[6] Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody [J].

Kahan, BD ;

Rajagopalan, PR ;

Hall, M .

TRANSPLANTATION, 1999, 67 (02) :276-284

[7] Economic analysis of basiliximab in renal transplantation [J].

Keown, PA ;

Balshaw, R ;

Krueger, H ;

Baladi, JF .

TRANSPLANTATION, 2001, 71 (11) :1573-1579

[8] Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3 [J].

Kode, RK ;

Kumar, AMS ;

Pankewycz, O ;

Damask, AM ;

Seirka, D ;

Lam, A ;

Phillips, K ;

Ardron, M ;

Brezin, J ;

Chvala, R ;

Kumar, MSA .

TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :1268-1269

[9] A prospective economic evaluation of basiliximab (Simulect®) therapy following renal transplantation [J].

Lorber, MI ;

Fastenau, J ;

Wilson, D ;

DiCesare, J ;

Hall, ML .

CLINICAL TRANSPLANTATION, 2000, 14 (05) :479-485

[10]

Mallick NP, 1997, NEPHROL DIAL TRANSPL, V12, P25

← 1 2 →